Aravive, Inc.
ARAVDelisted Jan 29, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513818
Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Aravive, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −3 vs. Q2 2021
- Shares held
- 4.75M
- −1.12M (−19.0%) vs. Q2 2021
- Total value
- $17.7M
- −$17.4M (−49.6%) vs. Q2 2021
- New holders
- 5
- 16 more added
- Sold out
- 8
- 16 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARAV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $373 |
| Q1 2026 | 1 | $373 |
| Q4 2025 | 2 | $373 |
| Q3 2025 | 1 | $373 |
| Q2 2025 | 1 | $373 |
| Q1 2025 | 1 | $373 |
| Q4 2024 | 2 | $373 |
| Q3 2024 | 1 | $373 |
| Q2 2024 | 1 | $373 |
| Q1 2024 | 3 | $69.4K |
| Q4 2023 | 30 | $825.5K |
| Q3 2023 | 33 | $786.9K |
| Q2 2023 | 35 | $21.5M |
| Q1 2023 | 36 | $36.9M |
| Q4 2022 | 32 | $20.1M |
| Q3 2022 | 28 | $3.24M |
| Q2 2022 | 36 | $5.47M |
| Q1 2022 | 37 | $10.1M |
| Q4 2021 | 36 | $9.99M |
| Q3 2021 | 45 | $17.7M |
| Q2 2021 | 49 | $35.3M |
| Q1 2021 | 59 | $42.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Aravive, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 33 | $0 | 0.00% | −2,241−98.5% | Reduced |
| BNP Paribas Arbitrage, SA | 361 | $1.34K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 700 | $2.00K | 0.00% | +700 | New |
| Tower Research Capital LLC (TRC) | 829 | $3.00K | 0.00% | +114+15.9% | Added |
| Newbridge Financial Services Group, Inc. | 841 | $3.00K | 0.00% | +311+58.7% | Added |
| Barclays PLC | 1,678 | $6.00K | 0.00% | −1,448−46.3% | Reduced |
| Advisor Group Holdings, Inc. | 2,269 | $8.00K | 0.00% | +662+41.2% | Added |
| Simplex Trading, LLC | 2,271 | $13.0K | 0.00% | +79+3.6% | Added |
| Massmutual Trust Co FSB | 9,300 | $35.0K | 0.00% | +9,300 | New |
| Susquehanna International Group, LLP | 10,570 | $39.0K | 0.00% | −22,326−67.9% | Reduced |
| Virtu Financial LLC | 10,861 | $40.0K | 0.00% | +10,861 | New |
| Schonfeld Strategic Advisors LLC | 11,500 | $43.0K | 0.00% | +100+0.9% | Added |
| Jacobs Levy Equity Management, Inc | 12,127 | $45.0K | 0.00% | +12,127 | New |
| Geneos Wealth Management Inc. | 12,810 | $47.0K | 0.00% | +7,200+128.3% | Added |
| Walleye Trading LLC | 14,371 | $53.0K | 0.00% | +4,370+43.7% | Added |
| Wells Fargo & Company | 20,067 | $74.0K | 0.00% | +729+3.8% | Added |
| ACT Capital Management, LLC | 23,500 | $87.0K | 0.05% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 24,794 | $92.0K | 0.00% | −30,449−55.1% | Reduced |
| Verition Fund Management LLC | 25,000 | $93.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 26,749 | $99.0K | 0.00% | −3,088−10.3% | Reduced |
| Marshall Wace, LLP | 28,462 | $106.0K | 0.00% | −162,958−85.1% | Reduced |
| Citadel Advisors LLC | 31,950 | $119.0K | 0.00% | −18,285−36.4% | Reduced |
| State Street Corp | 31,987 | $119.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 33,683 | $125.0K | 0.00% | −2,538−7.0% | Reduced |
| Federated Hermes, Inc. | 34,372 | $128.0K | 0.00% | −237−0.7% | Reduced |
| Bank of America Corp | 36,480 | $136.0K | 0.00% | +16,430+81.9% | Added |
| Franklin Resources Inc | 37,800 | $141.0K | 0.00% | +37,800 | New |
| Morgan Stanley | 40,786 | $151.0K | 0.00% | −143,385−77.9% | Reduced |
| Blair William & Co | 43,000 | $160.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 54,376 | $202.0K | 0.00% | +18,437+51.3% | Added |
| Walleye Capital LLC | 55,085 | $205.0K | 0.01% | +23,186+72.7% | Added |
| Ergoteles LLC | 57,598 | $214.0K | 0.01% | +1,998+3.6% | Added |
| UBS Group AG | 58,240 | $217.0K | 0.00% | −13,813−19.2% | Reduced |
| Bank of New York Mellon Corp | 58,818 | $219.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 82,625 | $307.0K | 0.01% | +50,000+153.3% | Added |
| Millennium Management LLC | 86,422 | $321.0K | 0.00% | −5,624−6.1% | Reduced |
| Dimensional Fund Advisors LP | 107,886 | $401.0K | 0.00% | −88,696−45.1% | Reduced |
| Two Sigma Investments, LP | 109,859 | $409.0K | 0.00% | −55,102−33.4% | Reduced |
| Geode Capital Management, LLC | 129,120 | $480.0K | 0.00% | +2,429+1.9% | Added |
| BlackRock Inc. | 172,886 | $644.0K | 0.00% | −3,793−2.1% | Reduced |
| Two Sigma Advisers, LP | 181,376 | $675.0K | 0.00% | −115,900−39.0% | Reduced |
| Renaissance Technologies LLC | 281,229 | $1.05M | 0.00% | +3,800+1.4% | Added |
| Vanguard Group Inc | 532,219 | $1.98M | 0.00% | +10,897+2.1% | Added |
| New Leaf Venture Partners, L.L.C. | 946,423 | $3.52M | 1.02% | 00.0% | Unchanged |
| Artal Group S.A. | 1,311,291 | $4.88M | 0.12% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −456,443−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −88,102−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −56,200−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −47,821−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −11,181−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| QS Investors, LLC | – | – | – | – | Not filed |